Skip to main content
Clinical Trials/JPRN-jRCTs051210118
JPRN-jRCTs051210118
Recruiting
未知

An experiment to examine the effects of oxytocin administration and menstrual cycle on competitive preference / social preference

Satoshi Nakagawa0 sites250 target enrollmentNovember 9, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Satoshi Nakagawa
Enrollment
250
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Satoshi Nakagawa

Eligibility Criteria

Inclusion Criteria

  • For those who meet all of the following criteria.
  • (1\) Premenopausal healthy women
  • (2\) Age: 18\<\= and \<45 at the point of informed consent
  • (3\) No serious disease under medical treatment
  • A healthy woman is defined as a woman who does not have any abnormality that meets the exclusi on criteria and who has not been found to have any abnormality that requires treatment in a school or workplace examination conducteds after fiscal 2021\.To determine the eligibility criteria,it is necessary to submit the results of a school or workplace medical checkup, and following items are confirmed by the
  • Check items:
  • (1\) The absence of significant edema
  • (2\) Systolic blood pressure \< 140 mgHg and diastolic blood pressure \< 90 mmHg
  • (3\) No possibility of pregnant
  • (4\) No ECG abnormalities that require awareness or treatment of arrhythmia

Exclusion Criteria

  • Those who fall under any of the following criteria will be excluded from the research subjects of this clinical research.
  • (1\) Pregnant and breastfeeding women(Including within 1 year after delivery)
  • (2\) History of tretment with oxytocin
  • (3\) History of head injury with impaired consciousness for more than 5 minutes
  • (4\) Drug dependence or alcohol dependence or their previous history
  • (5\) History of water intoxication with consciousness or seizures
  • (6\) Polydipsia (remarkably daily heavy drinking more than 2\.5L per day)
  • (7\) Those who are aware of arrhythmia or have abnormal ECG
  • (8\) Those who taking pill
  • (9\) Any other interested person

Outcomes

Primary Outcomes

Not specified

Similar Trials